Aurobindo Pharma’s arm recalls 59.5 thousand vials of antipsychotic injection from US

13 Dec 2019 Evaluate

Aurobindo Pharma’s arm -- AuroMedics Pharma LLC has initiated recall of 59.5 thousand vials of antipsychotic Fluphenazine Decanoate injection USP 125mg/5mL, (5 mL multiple dose vial) from the US market. The recalling of 59,500 vials of the injection is on account of ‘Discoloration; hazy solution found in one vial instead of a clear solution’.

The product was distributed to major wholesalers/distributors who may have further distributed the product throughout the US. The voluntary ongoing recall is a class II recall.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1221.70 26.05 (2.18%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.